Literature DB >> 9729164

CDF-1 mediated repression of cell cycle genes targets a specific subset of transactivators.

J Zwicker1, F C Lucibello, V Jérôme, S Brüsselbach, R Müller.   

Abstract

The cdc25C, cyclin A and cdc2 genes are regulated during the cell cycle through two contiguous repressor binding sites, the CDE and CHR, located in the region of transcription initiation and interacting with a factor termed CDF-1. The target of this repression seems to be transcriptional activation of these promoters by transcription factors bound upstream. The majority of these factors falls into the class of glutamine-rich activators, suggesting that CDF-1-mediated repression might be activation domain specific. In the present study we have used chimeric promoter constructs to demonstrate that the cdc25C UAS, but not the core promoter, is crucial for repression. In addition, we show that only specific transcription factors and activation domains are responsive to CDE-CHR-mediated cell cycle regulation. These observations clearly indicate that CDF-1 interferes with activation of transcription by a specific subset of transactivators. The repressible activation domains belong to the same class of glutamine-rich activators, pointing to specific interactions of CDF-1 with components of the transcription machinery. In agreement with this conclusion we find that a simple inversion of the CDF-CHR module completely abrogates cell cycle-regulated repression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729164      PMCID: PMC147365     

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  1 in total

1.  Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes.

Authors:  Guillermo Pablo Vicent; A Silvina Nacht; Roser Zaurin; Jofre Font-Mateu; Daniel Soronellas; Francois Le Dily; Diana Reyes; Miguel Beato
Journal:  Genes Dev       Date:  2013-05-15       Impact factor: 11.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.